NEUMOLOGÍA PEDIÁTRICA

57 / 64

101 Contenido disponible en
al. Evaluation of the utility of radiography in acute bronchiolitis. J
Pediatr 2007; 150 (4): 429-33.
32. Nebot MS, Teruel GC, Cubells CL, Sabadell MD, Fernández
JP. Guía de práctica clínica sobre la bronquiolitis aguda:
recomendaciones para la práctica clínica. An Pediatr (Barc) 2010;
73: 208.e1-e10.
33. España. Ministerio de Sanidad y Política Social. Guía de práctica
clínica sobre bronquiolitis aguda. Madrid: Ministerio de Ciencia e
Innovación; 2010.
34. Subcommittee on Diagnosis and Management of Bronchiolitis.
Diagnosis and management of bronchiolitis. Pediatrics 2006; 118:
1774-93.
35. Gadomski AM, Brower M. Bronchodilators for bronchiolitis.
Cochrane Database Syst Rev 2010; 12: CD001266.
36. Martinón-Torres F, Rodríguez Núñez A, Martinón Sánchez JM.
Protocolos terapéuticos. Bronquiolitis aguda: evaluación del
tratamiento basada en la evidencia. An Esp Pediatr 2001; 55: 345-
54.
37. Baquero Rodríguez R, Granadillo Fuentes A. Guía práctica clínica:
bronquiolitis. Salud Uninorte 2009; 25: 135-49.
38. Hartling L, Wiebe N, Russell K, Patel H, Klassen TP. Epinephrine for
bronchiolitis. Cochrane Database Syst Rev 2004; 1: CD003123.
39. González de Dios J, Ochoa Sangrador C; Grupo de Revisión
del Proyecto abreviado (Bronquiolitis-Estudio de Variabilidad,
Idoneidad y Adecuación). [Consensus conference on acute
bronchiolitis (IV): Treatment of acute bronchiolitis. Review of
scientific evidence]. An Pediatr (Barc) 2010; 72 (4): 285.
40. Fernandes RM, Bialy LM, Vandermeer B, Tjosvold L, Plint AC,
Patel H, et al. Glucocorticoids for acute viral bronchiolitis in infants
and young children. Cochrane Database Syst Rev 2010; 10:
CD004878.
41. Somers CC, Ahmad N, Mejias A. Effect of dexamethasone on
respiratory syncytial virus-induced lung inflammation in children:
results of a randomized, placebo controlled clinical trial. Pediatr
Allergy Immunol 2009; 20: 477-85.
42. Van Woensel JB, Vyas H; STAR Trial Group. Dexamethasone in
children mechanically ventilated for lower respiratory tract infection
caused by respiratory syncytial virus: a randomized controlled trial.
Crit Care Med 2011; 39: 1779-83.
43. Amirav I, Luder AS, Kruger N, Borovitch Y, Babai I, Miron D,
et al. A Double-Blind, Placebo-Controlled, Randomized Trial of
Montelukast for Acute Bronchiolitis. Pediatrics 2008; 122: e1249-
55.
44. Tahan F, Ozcan A, Koc N. Clarithromycin in the treatment of RSV
bronchiolitis: a double-blind, randomised, placebo-controlled trial.
Eur Respir J 2007; 29: 91-7.
45. Spurling GKP, Fonseka K, Doust J, Del Mar C. Antibiotics for
bronchiolitis in children (Review). Cochrane Database Syst Rev
2007; 1: CD005189.
46. Perrotta C, Ortiz Z, Roque M. Chest physiotherapy for acute
bronchiolitis in paediatric patients between 0 and 24 months old.
Cochrane Database Syst Rev 2007; 1: CD004873.
47. Kuzik BA, Al-Qadhi SA, Kent S, Flavin MP, Hopman W, Hotte S, et
al. Nebulized hypertonic saline in the treatment of viral bronchiolitis
in infants. J Pediatr 2007;151 (3): 266-70.
48. Sarrell EM, Tal G, Witzling M, Someck E, Houri S, Cohen HA, et al.
Nebulized 3% hypertonic saline solution treatment in ambulatory
children with viral bronchiolitis decreases symptoms. Chest 2002;
122 (6): 2015-20.
49. Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulized
hypertonic saline solution for acute bronchiolitis in infants.
Cochrane Database Syst Rev 2008; 4: CD006458.
50. Morawetz D, Cheah E, Barton R, Standish J, Connell TG. Is
nebulised hypertonic saline useful as an adjunctive treatment for
acute bronchiolitis in infants and children less than 24 months of
age? J Paediatr Child Health 2011; 47 (12): 922-6.
51. Ipek IO, Yalcin EU, Sezer RG, Bozaykut A. The efficacy of nebulized
salbutamol, hypertonic saline and salbutamol/hypertonic saline
combination in moderate bronchiolitis. Pulm Pharmacol Ther
2011; 24 (6): 633-7.
52. Ralston S, Hill V, Martinez M. Nebulized hypertonic saline without
adjunctive bronchodilators for children with bronchiolitis. Pediatrics
2010; 126 (3): e520-5.
53. Luo Z, Fu Z, Liu E, Xu X, Fu X, Peng D, et al. Nebulized
hypertonic saline treatment in hospitalized children with moderate
to severe viral bronchiolitis. Clin Microbiol Infect 2011; 17: 1829-
33.
54. Kuzik BA, Flavin MP, Kent S, Zielinski D, Kwan CW, Adeleye A, et
al. Effect of inhaled hypertonic saline on hospital admission rate in
children with viral bronchiolitis: a randomized trial. CJEM 2010; 12
(6): 477-84.
55. Al-Ansari K, Sakran M, Davidson BL, El Sayyed R, Mahjoub H,
Ibrahim K. Nebulized 5% or 3% hypertonic or 0.9% saline for
treating acute bronchiolitis in infants. J Pediatr 2010; 157 (4): 630-
4, 634.e1.
56. Carbonell Estrany X, Quero Jiménez J; Comité de Estándares
de la Sociedad Española de Neonatología y Junta Directiva de la
Sociedad Española de Neonatología. Recomendaciones para la
prevención de la infección del virus respiratorio sincitial. An Esp
Pediatr 2000; 52: 372-4.
57. Committee on Infectious Diseases. From the American Academy of
Pediatrics: Policy statements-Modified recommendations for use of
palivizumab for prevention of respiratory syncytial virus infections.
Pediatrics 2009; 124 (6): 1694-701.
Bronquiolitis: artículo de revisión - Parra A. et al Neumol Pediatr 2013; 8 (2): 95-101.